Andrew Simmelink

Andrew Simmelink practices at Richmond Gastroenterology Associates, Inc. in Richmond, Virginia.

Andrew Simmelink's NPI, 1295120061, was assigned on March 30, 2015. Andrew Simmelink graduated from Eastern Virginia Medical School in 2015. Andrew Simmelink holds Virginia license 0101272213.

Andrew Simmelink's primary practice is Richmond Gastroenterology Associates, Inc., at 2369 Staples Mill Rd, Richmond, VA 23230 in Henrico County. The practice phone is (804) 330-4901.

Andrew Simmelink's primary practice is Richmond Gastroenterology Associates, Inc. in Richmond, Virginia. Andrew Simmelink is also affiliated with Bon Secours St. Mary's Hospital. The medical group on file is Richmond Gastroenterology Associates. Dmand AI also links Andrew Simmelink to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Andrew Simmelink practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Andrew Simmelink's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Andrew Simmelink's licenses on file in 2 states: Virginia and North Carolina.

CMS data shows 744 Medicare services from Andrew Simmelink across 18 procedure codes in 2024, for 457 Medicare patients. Medicare paid $91,464 for them.

CMS counts 457 Medicare patients who saw Andrew Simmelink in 2024. The largest group is 65 to 74, with 240 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Andrew Simmelink's median patient age at 59, with 57% women.

In 2024, Andrew Simmelink wrote 1,157 Medicare Part D claims for 532 patients. 84% of them were for generic drugs. CMS names the drug for 990 of them, across 14 drugs with 11 or more claims each, at $80,382 in total drug cost. In 2023, CMS named 524 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Andrew Simmelink for performance year 2024, reported as part of a group. Andrew Simmelink accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Andrew Simmelink as offering telehealth. CMS counts 212 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Andrew Simmelink, more than 91% of the clinicians it reports for that procedure.

CMS Open Payments shows 316 general payments to Andrew Simmelink from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $4,482.

Andrew Simmelink graduated from Eastern Virginia Medical School in 2015.